DENVER, April 24 /PRNewswire-FirstCall/ -- Global Med Technologies, Inc. (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, today announced that its Wyndgate Technologies(R) division has signed an agreement to license its SafeTrace(R) donor management system to St. Joseph's Healthcare System (St. Joseph's) located in Paterson, New Jersey. SafeTrace will be used to monitor blood donations for St. Joseph's Regional Medical Center's blood bank. Terms of the agreement were not disclosed.
Wyndgate's SafeTrace system will help St. Joseph's manage the volume of information needed to successfully administer a large healthcare system's blood bank, including donor scheduling, blood product manufacturing and infectious disease testing. In addition, SafeTrace will enable St. Joseph's to continue meeting the highest standards in the industry -- such as the ISBT 128 blood component labeling standard.
Wm. Scott Dustin, Vice President of Sales and Marketing for Wyndgate Technologies, commented, "After careful research, St. Joseph's felt that Wyndgate's SafeTrace system was the right software fit for their organization's complex needs. St. Joseph's Healthcare System has a 140-year heritage of providing quality care to the people of northern New Jersey regardless of their ability to pay. We feel that our SafeTrace donor management system will help St. Joseph's to further this legacy by helping to streamline many of their critical processes, realize cost savings from reduced waste and help to provide quality blood products to their hospitals."
About St. Joseph's Healthcare System
Founded by the Sisters of Charity of Saint Elizabeth in 1867, St. Joseph's Regional Medical Center, a private, non-profit facility, is now the hub of the multifaceted St. Joseph's Healthcare System. What began as a 12-bed hospital is now a 792-bed academic tertiary medical center and Level 2 Trauma Center staffed by more than 900 board certified physicians. Also included in the system are St. Joseph's Children's Hospital, a 120-bed state designated, full service children's hospital, St. Joseph's Wayne Hospital, a 229-bed acute care hospital, and St. Vincent's Nursing Home in Cedar Grove. From 102 patients in the first year of operation to more than 1.3 million patient visits in 2007, St. Joseph's continues to provide a comprehensive spectrum of services designed to heal the minds, bodies and spirits of those in need.
About Global Med Technologies, Inc.
Global Med Technologies(R), Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies(R) division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are also being used in Canada, Africa, and the Caribbean. Wyndgate's software provides Vein-to-Vein(R) tracking from donor collection to patient transfusion through its Donor Doc(TM) interactive donor health history questionnaire, ElDorado Donor(TM) and SafeTrace(R) donor management systems, to its SafeTrace Tx(R) advanced transfusion management system. Global Med's PeopleMed(R), Inc. subsidiary provides custom software validation, consulting and compliance solutions to hospitals and blood centers. PeopleMed's in-depth knowledge of Wyndgate's products and the blood banking industry results in cost-effective validation services, which leads to more efficient software implementations and upgrades for our customers.
For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com, http://www.peoplemed.com and http://www.wyndgate.com.
This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
SOURCE Global Med Technologies, Inc.